Literature DB >> 22922545

Ischemic stroke on awakening: patients' characteristics, outcomes and potential for reperfusion therapy.

Silvia Koton1, David Tanne, Natan M Bornstein.   

Abstract

BACKGROUND: Reports on differences between patients with and without wake-up stroke are inconsistent. We studied the proportion, characteristics, and outcomes of wake-up ischemic stroke (IS) and estimated the number of potential candidates for reperfusion therapy in a national registry of hospitalized patients.
METHODS: IS patients in all three National Acute Stroke ISraeli (NASIS) registry periods (2004, 2007, and 2010; 2 months each) were included. In-hospital neurological complications, poor functional outcome (death, modified Rankin scale ≥ 2, or discharge to a nursing home), and in-hospital mortality were the study outcomes. Risks of poor outcomes were estimated with logistic regression analysis.
RESULTS: Wake-up IS was reported for 820/4,408 (18.6%) patients. Baseline characteristics were similar for patients with and without wake-up IS. ORs (95% CIs) for wake-up compared to non-wake-up IS were 1.2 (0.9-1.6) for neurological complications, 0.8 (0.7-0.98) for poor functional outcome, and 0.8 (0.5-1.2) for death. According to an estimated 20-40% prevalence of penumbra, wake-up stroke patients could add 3.7-7.4% to the number of patients potentially eligible for reperfusion therapy.
CONCLUSIONS: Stroke on awakening is present in almost one fifth of IS patients. Characteristics and stroke outcomes are similar for patients with and without wake-up IS. Confirmation of a valid approach for the detection of wake-up stroke patients who can potentially benefit from reperfusion therapy is essential.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 22922545     DOI: 10.1159/000341242

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  11 in total

1.  Wake-up stroke and unknown-onset stroke; occurrence and characteristics from the nationwide Norwegian Stroke Register.

Authors:  Mary-Helen Søyland; Arnstein Tveiten; Agnethe Eltoft; Halvor Øygarden; Torunn Varmdal; Bent Indredavik; Ellisiv B Mathiesen
Journal:  Eur Stroke J       Date:  2022-04-06

Review 2.  What to do With Wake-Up Stroke.

Authors:  Mark N Rubin; Kevin M Barrett
Journal:  Neurohospitalist       Date:  2015-07

3.  IV thrombolysis for treatment of patients with stroke upon awakening: Yes? No?

Authors:  Harold P Adams
Journal:  Neurol Clin Pract       Date:  2015-08

4.  Wake-up Strokes Are Similar to Known-Onset Morning Strokes in Severity and Outcome.

Authors:  M C Denny; A K Boehme; A M Dorsey; A J George; A D Yeh; K C Albright; S Martin-Schild
Journal:  J Neurol Neurol Disord       Date:  2014-12-29

5.  Negative fluid-attenuated inversion recovery-based intravenous thrombolysis using recombinant tissue plasminogen activator in acute stroke patients with unknown onset time.

Authors:  Junya Aoki; Kazumi Kimura; Kensaku Shibazaki; Yuki Sakamoto
Journal:  Cerebrovasc Dis Extra       Date:  2013-03-23

6.  Safety of intravenous alteplase within 4.5 hours for patients awakening with stroke symptoms.

Authors:  Victor C Urrutia; Roland Faigle; Steven R Zeiler; Elisabeth B Marsh; Mona Bahouth; Mario Cerdan Trevino; Jennifer Dearborn; Richard Leigh; Susan Rice; Karen Lane; Mustapha Saheed; Peter Hill; Rafael H Llinas
Journal:  PLoS One       Date:  2018-05-22       Impact factor: 3.240

Review 7.  Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis.

Authors:  Teruyuki Hirano
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-09-15       Impact factor: 1.742

Review 8.  Wake-up stroke and stroke of unknown onset: a critical review.

Authors:  Anke Wouters; Robin Lemmens; Patrick Dupont; Vincent Thijs
Journal:  Front Neurol       Date:  2014-08-12       Impact factor: 4.003

9.  Hypoxic preconditioning stimulates angiogenesis in ischemic penumbra after acute cerebral infarction.

Authors:  Sijie Li; Yanbo Zhang; Guo Shao; Mingfeng Yang; Jingzhong Niu; Guowei Lv; Xunming Ji
Journal:  Neural Regen Res       Date:  2013-11-05       Impact factor: 5.135

10.  THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial.

Authors:  Masatoshi Koga; Kazunori Toyoda; Kazumi Kimura; Haruko Yamamoto; Makoto Sasaki; Toshimitsu Hamasaki; Takanari Kitazono; Junya Aoki; Kenta Seki; Kazunari Homma; Shoichiro Sato; Kazuo Minematsu
Journal:  Int J Stroke       Date:  2014-08-04       Impact factor: 5.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.